Category Archives: RxUSA Lawsuit

PDMA, RxUSA Lawsuit

Impact of RxUSA v. HHS On Future Pedigree Legislation

5 Comments

I attended the Partnership for Safe Medicines (PSM) Interchange 2011 conference on October 27 in Washington DC.  (I’ll cover that event more fully in a future essay.)  For me, the event couldn’t have been better, but I measure events like this perhaps a little differently than most people.  The agenda is important and the quality of the speakers is absolutely important, but in my view those are simply the things that lead to the one thing that can transform a merely good conference into a great conference:  the quality of the attendees.

(The quality of the attendees is exactly why I like the HDMA Track and Trace Seminar.  BTW, this year’s HDMA event starts this Thursday).

In the case of this year’s PSM event, I rate the quality of the attendees very high, and that’s because I had a number of great conversations with some very knowledgeable people during the breaks and at the social event the evening before.  That was my interaction with the attendees, not the speakers.  One of the topics of conversation surrounded the question of what exactly it was the led to the successful challenge to the Prescription Drug Marketing Act (PDMA) pedigree provisions in the RxUSA v. HHS court case and appeal and whether or not the same thing might occur with other drug pedigree laws.

AN IMPORTANT QUESTION GOES UNANSWERED

One of the first speakers at the PSM event was U.S. Representative Jim Matheson (D-UT), sponsor of H.R.3026, the “Safeguarding America’s Pharmaceuticals Act of 2011” which was introduced into the House of Representatives on September 22, 2011.  There are some differences, but the core of this new bill is basically the same as Continue reading Impact of RxUSA v. HHS On Future Pedigree Legislation →

PDMA, Pharmaceutical Commerce, RxUSA Lawsuit, Supply Network Blog, SupplyScape, TraceLink

PDMA Lawsuit Resolved?

1 Comment

I recently read in Pharmaceutical Commerce online magazine about the apparent resolution of the RxUSA lawsuit that had delayed implementaton of a couple of the pedigree provisions of the Federal PDMA (Prescription Drug Marketing Act).  While Pharmaceutical Commerce did its usual great job of providing historical context, I thought it might be an appropriate topic for the RxTrace blog.  But before I had time to document the history of the PDMA in my own words, Brian Daleiden beat me to it in the Supply Network Blog.  So rather than writing my own version, I gladly refer you to his post.  Between the Pharmaceutical Commerce article and Brian’s post, I have nothing more to say right now.

The Supply Network Blog is a fairly new publication of TraceLink, the successor to SupplyScape, my former employer.  I look forward to hearing more from their blog in the future so I recently subscribed.  Check it out and see what you think.